RELAY THERAPEUTICS INC

$RLAY
Smart money positioned

10 of the Top-200 alpha managers hold $RLAY as of the latest 13F snapshot.

13F holders
234
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

10 holders · Q1 2026

$RLAY is held by 10 managers from the Top-Performer cohort as of Q1 2026. Position weights range from 0.00% to 1.85%, with an average of 0.21% of portfolio. Largest holder: Bellevue Group AG at 1.85%. A weekly Smart-Money commentary for this ticker has not been generated yet this batch — the table below shows the full cohort positioning.

Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.

Institutional holders

Top 10 of 234 · Source: 13F-HR
01
Marquard & Bahls AG
10.92% of portfolio
28,837,148 sh
02
Crewe Advisors LLC
3.59% of portfolio
27,904,963 sh
03
Vernal Point Advisors, LLC
9.79% of portfolio
17,000,000 sh
04
Rokos Capital Management LLP
1.85% of portfolio
15,586,636 sh
05
Point72 Asset Management, L.P.
0.14% of portfolio
14,773,676 sh
06
Vida Ventures Advisors, LLC
1.23% of portfolio
8,546,712 sh
07
State Street
6,426,111 sh
08
Axa S.a.
6,233,545 sh
09
Garde Capital, Inc.
3.87% of portfolio
5,526,506 sh
10
Atlantic Edge Private Wealth Management, LLC
4,803,032 sh
See all 234 13F holders · Pro →

Insider activity · last 90 days

No insider activity

No Form 4 filings on record for $RLAY in the recent window.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $RLAY in the recent window.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 07:20 UTC.